Effect of CPAP Treatment on Cardiovascular Outcomes
Arch Bronconeumol. 2024 Oct;60(10):627-633.
doi: 10.1016/j.arbres.2024.05.029.
Epub 2024 May 31.
[Article in
English,
Spanish]
Affiliations
- 1 Group of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain. Electronic address: [email protected].
- 2 Group of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
- 3 Chronic Care Program (Hospital Clínic) & Master Plan for Respiratory Diseases (Department of Health, Catalonia) & REDISSEC, Barcelona, Spain.
- 4 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Institut d'Investigació Biomèdica (IIB Sant Pau), Barcelona, Spain.
- 5 Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, Spain.
- 6 Group of Translational Research in Respiratory Medicine, IRBLleida, Hospital Universitari Arnau de Vilanova and Santa Maria, Lleida, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Núcleo de Investigación en Ciencias de la Salud, Universidad Adventista de Chile, Chillán, Chile.
- 7 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Group of Precision Medicine in Chronic Diseases, Hospital Nacional de Parapléjicos, Toledo, Spain; Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), Castilla-La Mancha, Spain; Department of Nursing, Physiotherapy and Occupational Therapy, Faculty of Physiotherapy and Nursing, University of Castilla-La Mancha, Toledo, Spain.
Abstract
Introduction:
Randomized controlled trials (RCT) have not demonstrated a role for continuous positive airway pressure (CPAP) on the secondary prevention of major cardiovascular events in obstructive sleep apnea (OSA) patients. However, participants in RCTs are substantially different from real-world patients. Therefore, we aimed to assess the effect of CPAP treatment on major cardiovascular events in real-world OSA patients.
Methods:
Population-based longitudinal observational study including all OSA patients with an active CPAP prescription at the beginning of 2011 in Catalonia, Spain, that terminated CPAP treatment during 2011 and did not have CPAP prescriptions between 2012-2015; and propensity-score-matched OSA patients that continued CPAP treatment until the end of 2015 or death. Adjusted hazard ratios were used to assess the association between CPAP treatment and overall and cardiovascular mortality, cardiovascular hospitalizations, or major adverse cardiovascular events (MACEs).
Results:
3638 CPAP terminators and 10,914 propensity-score-matched continuators were included (median age 67 [57-77] years, 71.4% male). During a median follow-up of 47.9 months CPAP continuators showed a lower risk of cardiovascular death than terminators (hazard ratio [HR]: 0.61; 95% confidence interval [CI]: 0.50-0.75) after adjusting by age, sex and key comorbidities. Similar results were found for cardiovascular hospitalizations (HR: 0.87; 95% CI: 0.76-0.99) and MACEs (HR: 0.84; 95% CI: 0.75-0.95).
Conclusion:
CPAP treatment continuation could be associated with a significantly lower risk of major cardiovascular events in real-world OSA patients. This result highlights the importance of including real-world patients in studies on OSA.
Keywords:
Cardiovascular outcomes; Continuous positive airway pressure (CPAP); Mortality; Obstructive sleep apnea; Population-based study.
Copyright © 2024 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Aged
-
Cardiovascular Diseases* / epidemiology
-
Cardiovascular Diseases* / etiology
-
Cardiovascular Diseases* / mortality
-
Cardiovascular Diseases* / prevention & control
-
Continuous Positive Airway Pressure*
-
Female
-
Hospitalization / statistics & numerical data
-
Humans
-
Longitudinal Studies
-
Male
-
Middle Aged
-
Propensity Score
-
Secondary Prevention
-
Sleep Apnea, Obstructive* / complications
-
Sleep Apnea, Obstructive* / therapy
-
Spain / epidemiology
-
Treatment Outcome